| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,003 | 0,020 | 16:04 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.10. | Imaging Biometrics - Strengthening pipeline prominent US institutions | - | RNS | ||
| 15.09. | Imaging Biometrics secures U.S. healthcare system contract | 2 | Investing.com | ||
| 15.09. | Imaging Biometrics sichert sich Vertrag mit US-Gesundheitssystem | 2 | Investing.com Deutsch | ||
| 15.09. | Imaging Biometrics - Adoption of Advanced Brain Tumor Imaging Platform | - | RNS | ||
| IMAGING BIOMETRICS Aktie jetzt für 0€ handeln | |||||
| 28.08. | Imaging Biometrics gewinnt US-Klinikum als Abonnenten für Hirntumor-Software | 1 | Investing.com Deutsch | ||
| 28.08. | Imaging Biometrics secures US medical center subscription | 1 | Investing.com | ||
| 28.08. | Imaging Biometrics - US Academic Medical Centre Adopts IB Clinic | - | RNS | ||
| 29.07. | Imaging Biometrics - Half Yearly Report to 30 June 2026 | - | RNS | ||
| 15.07. | Amendment Notice - Imaging Biometrics Limited | 299 | Dow Jones News | DJ Amendment Notice - Imaging Biometrics Limited
Financial Conduct Authority (-)
Amendment Notice - Imaging Biometrics Limited
15-Jul-2026 / 08:00 GMT/BST
=----------------------------------------------------------------------------------------------------------------------... ► Artikel lesen | |
| 14.07. | Imaging Biometrics - Sub-division | - | RNS | ||
| 09.06. | Imaging Biometrics veröffentlicht Phase-1-Studiendaten zu Glioblastom-Medikament | - | Investing.com Deutsch | ||
| 09.06. | Imaging Biometrics publishes trial results for glioblastoma drug | 3 | Investing.com | ||
| 09.06. | Imaging Biometrics - Publication of Phase 1 Clinical Trial | - | RNS | ||
| 05.06. | Imaging Biometrics eyes incremental revenue from IB Neuro technology | 1 | Alliance News | ||
| 05.06. | WINNERS & LOSERS: Evoke agrees bid; Imaging Biometrics positive trials | 3 | Alliance News | ||
| 05.06. | Software von Imaging Biometrics zeigt in Phase-II-Studie frühe Wirksamkeitssignale bei Hirntumoren | 1 | Investing.com Deutsch | ||
| 05.06. | Imaging Biometrics reports phase II trial results for brain tumor software | 1 | Investing.com | ||
| 05.06. | Imaging Biometrics - Commercialisation, Phase II Results & Revenue Path | - | RNS | ||
| 03.06. | Imaging Biometrics - Result of AGM | - | RNS | ||
| 03.06. | Imaging Biometrics - AGM Statement and Business Update | - | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GERRESHEIMER | 32,960 | +3,32 % | Kurssprünge und neue Aufträge: Wie belastbar ist die Wende? dynaCERT, Gerresheimer, Steyr Motors | Ein Übernahmeangebot, internationale Vertriebsfortschritte und ein Konzernumbau bringen Bewegung in die folgenden drei Börsenwerte. Während Anleger auf neue Wachstumsimpulse und finanzielle Entlastung... ► Artikel lesen | |
| MCKESSON | 906,20 | +3,09 % | NSE - MCKESSON CORP - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| LIMES SCHLOSSKLINIKEN | 515,00 | -1,90 % | Aktien KW 36 Iran, Zinsangst und Trump-"unsinn" bremsen - was wäre wenn? News. Rheinmetall. Vonovia. DEFAMA. Smartbroker. Sino. Trade Republic. Limes Schlosskliniken. Mutares. Symrise. Aroundtown. Enapter. Bilfinger. Nagarro. Haier Smart. Delivery Hero | Aktien - diese Woche im Niemandsland. Positiv am Ende der Woche steht wieder 26 am Anafng des DAX, aber Schwung nach oben fehlt. Impulse hätten Nvidia und die anderen Ki-Aktien mit teilweise beeindruckenden... ► Artikel lesen | |
| BEYOND AIR | 2,320 | -2,11 % | Beyond Air Receives FDA Breakthrough Device Designation for LungFit GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) | GARDEN CITY, N.Y., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
| HEALTHCARE SERVICES GROUP | 22,000 | 0,00 % | HEALTHCARE SERVICES GROUP INC - 10-Q, Quarterly Report | ||
| ADDUS HOMECARE | 108,00 | 0,00 % | Raymond James startet Coverage für Addus HomeCare mit "Outperform" | ||
| INTERPACE BIOSCIENCES | - | - | Interpace Biosciences, Inc.: Interpace Biosciences Announces Reverse Stock Split to Support Proposed Nasdaq Uplisting | PARSIPPANY, NJ, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCID: IDXG) ("Interpace" or the "Company"), an emerging leader in enabling personalized medicine, today announced that... ► Artikel lesen | |
| MODERN DENTAL | 0,810 | -1,82 % | Modern Dental Group Limited: CICC Initiates Coverage of Modern Dental Group (03600.HK) with Outperform Rating and Target Price of HK$10.0: Accelerating Global Expansion with Digital Efficiency | HONG KONG, Oct 12, 2026 - (ACN Newswire) - CICC initiates coverage on Modern Dental Group (03600.HK) with an 'Outperform' rating and a target price of HK$10.00, highlighting three key drivers. 1) Digitalization-led... ► Artikel lesen | |
| ICU MEDICAL | 149,00 | -1,32 % | Biotech Stocks At 52-Week Highs - Anika Therapeutics & Chemed Corporation Rise With Q2 Results, ICU Medical, Neurocrine Biosciences, Royalty Pharma | LONDON (dpa-AFX) - The following biotech stocks reached a 52-week high on July 29, 2026, driven by key catalysts such as the release of second quarter financial results and ongoing clinical... ► Artikel lesen | |
| ACADIA HEALTHCARE | 26,200 | 0,00 % | Biotech Stocks At 52-Week Highs - Cumberland Pharmaceuticals, Maravai LifeSciences, AngioDynamics, Acadia Healthcare, Teladoc Health | BENTONVILLE (dpa-AFX) - The following biotech stocks reached a 52-week high on July 15, 2026, driven by catalysts such as recent business developments or positive quarterly reports.Cumberland... ► Artikel lesen | |
| THERACLION | 0,700 | +7,69 % | Theraclion Announces the Initiation of Coverage by TP ICAP Midcap With a Target Price of EUR 1.70, Confirming the Potential of Sonovein | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused... ► Artikel lesen | |
| MEDIPAL | 19,700 | +3,68 % | Silchester International Investors LLP: Silchester International Investors - Press Release - Medipal Holdings Corporation (7459:JT) | Silchester International Investors - Press Release - Medipal Holdings Corporation (7459:JT)
LONDON, Oct. 28, 2026 /PRNewswire/ -- Silchester International Investors LLP ("Silchester"), acting on... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,460 | -2,44 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC auf "Underweight" mit einem Kursziel von 32,30 Euro belassen. Entgegen seinen Erwartungen seien die Konsensschätzungen an die Quartalszahlen... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 67,02 | +11,29 % | BrightSpring Health Q3 2026 Earnings Call Transcript | ||
| SIEMENS HEALTHINEERS | 43,030 | +0,33 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen |